Takeda Pharmaceutical Co Ltd QDENGA Investor Call Transcript
Good morning, good evening, everyone. This is Elizabeth Borgeson. As part of the IR team at Takeda, I'd like to welcome you to our event, where we will be discussing our new dengue vaccine QDENGA. (Operator Instructions)
Moving to Slide 2. I'd like to remind everyone that I'll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Also refer to the important notice on Slide 2 of the presentation.
We have a great presentation for you today. So without further ado, let me introduce Ramona Sequeira, President of Global Portfolio division. Ramona, I'll hand it over to you to introduce the rest of the team.
Thank you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |